Back to News & Events

Could Pharma, Digitial Therapeutics Partnership Be a $1B Opportunity?

A panel discussion at the DTx East conference in Boston discussed whether partnerships between digital health and drugmakers were “a match made in heaven.”

You may also like

Enhancing Multiple Sclerosis Patient Outcomes Through Digital Engagement

Multiple Sclerosis (MS) represents a formidable challenge in healthcare, a chronic, often unpredictable disease of the central nervous system that 

..Read More

Boosting Diabetes Adherence: Medisafe Digital Tools Deliver Results

Summary Managing diabetes presents significant challenges both for patients and pharmaceutical companies. Adherence to medication regimens, continuous monitoring, and lifestyle 

..Read More

High-Stakes GLP-1s: Where Digital Reinforcement Becomes Mission-Critical

Today’s groundbreaking announcement from Novo Nordisk and Eli Lilly to reduce the cost of their blockbuster weight loss drugs in 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.

Contact Us